Evolent Health, Inc.
EVH
$9.41
-$0.13-1.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.45% | -1,549.69% | 109.24% | 48.28% | -31.93% |
| Total Depreciation and Amortization | 96.53% | 1.00% | -0.14% | 0.87% | -10.86% |
| Total Amortization of Deferred Charges | -0.93% | -2.61% | 3.70% | -19.66% | 5.13% |
| Total Other Non-Cash Items | -38.00% | 20.95% | -51.79% | -2.61% | 16.08% |
| Change in Net Operating Assets | -552.51% | 73.31% | 32.19% | -164.30% | 143.29% |
| Cash from Operations | -240.50% | -12.83% | 336.28% | -94.51% | 47.69% |
| Capital Expenditure | 114.87% | -48.17% | -73.32% | -11.24% | 10.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.99% | -30.27% | 37.57% | -- | -100.00% |
| Cash from Investing | -1.02% | -45.70% | -39.14% | -60.81% | 1.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 99.87% | -4,067.01% |
| Issuance of Common Stock | -- | 3,740.98% | -94.23% | -68.29% | -26.34% |
| Repurchase of Common Stock | 55.20% | -90.11% | 97.46% | -1,418.43% | 41.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 6.39% | -1.32% | 0.22% | 1.63% | -1.30% |
| Other Financing Activities | 877.43% | 94.36% | -390.27% | 159.96% | -123.49% |
| Cash from Financing | 1,176.18% | 91.29% | -794.67% | 117.64% | -125.74% |
| Foreign Exchange rate Adjustments | -338.71% | -29.17% | 36.84% | -111.11% | 83.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 601.53% | 89.43% | -1,053.29% | 1,062.63% | -106.16% |
